Status:
COMPLETED
Neramexane for Tinnitus
Lead Sponsor:
Merz Pharmaceuticals GmbH
Conditions:
Tinnitus
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
Tinnitus is commonly referred to as "ringing of the ears" - the perception of sounds in the absence of an external source of acoustic signals. Tinnitus may represent a severe disease and symptoms incl...
Eligibility Criteria
Inclusion
- main inclusion criterion: persistent, subjective, uni- or bilateral tinnitus
Exclusion
- main exclusion criterion: intermittent or pulsatile tinnitus
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2007
Estimated Enrollment :
431 Patients enrolled
Trial Details
Trial ID
NCT00405886
Start Date
October 1 2005
End Date
March 1 2007
Last Update
March 11 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Vienna, Austria
2
Munich, Germany